Engineers Gate Manager’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$259K Buy
86,231
+23,267
+37% +$90K ﹤0.01% 1786
2025
Q4
$383K Buy
62,964
+21,780
+53% +$198K ﹤0.01% 1498
2025
Q3
$453K Buy
+41,184
New +$365K 0.01% 1564

Other funds holding XGN

Engineers Gate Manager's XGN Position: Q1 2026 in Review

Engineers Gate Manager increased its Exagen (XGN) stake by 37% in Q1 2026, buying an estimated $90K and bringing the position to 86,231 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #1786.

Engineers Gate Manager first reported a position in XGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $453K in Q3 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Engineers Gate Manager held 86,231 shares of Exagen worth $259K as of Q1 2026.
  • Engineers Gate Manager bought 23,267 Exagen shares in Q1 2026, an estimated $90K.
  • Exagen made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1786 holding.
  • Engineers Gate Manager first reported a position in Exagen in Q3 2025 and has held it in 3 quarters since.
  • Engineers Gate Manager's Exagen position peaked at $453K in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.